Evaluation of diabetic retinopathy progression in subjects with type 2 diabetes mellitus treated with insulin.

Trial Profile

Evaluation of diabetic retinopathy progression in subjects with type 2 diabetes mellitus treated with insulin.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2009

At a glance

  • Drugs Insulin glargine; Insulin suspension isophane
  • Indications Diabetic retinopathy; Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Jul 2009 5-year follow up data were presented in a sanofi aventis media release, were reported on-line in Diabetologia.
    • 14 Sep 2007 Status changed from in progress to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top